Delivery Order V797P7347A-36C24820F0096
- Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostic solutions, has been awarded a $685,337.42 delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 8 for performance in Castleton, Indiana. The contract, awarded October 1, 2025, with completion targeted for April 30, 2026, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued as a child contract under Roche Diagnostics' existing...
- Roche Diagnostics Corporation has been awarded a $866.67K delivery order by Veterans Integrated Service Network 20, a civilian component of the Department of Veterans Affairs, with a firm fixed-price structure. The contract covers laboratory reagents and consumables priced on a cost-per-reportable-result basis, with an ultimate completion date of February 10, 2026. The award represents a child contract under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration...
- Roche Diagnostics Corporation has been awarded a delivery order contract valued at $327,951.52 for laboratory equipment and supplies, with an ultimate completion date of October 31, 2024. This contract was issued by the Veterans Integrated Service Network 20, a civilian component of the Department of Veterans Affairs, and is based in Castleton, Indiana. The award represents a firm fixed-price delivery order under Roche Diagnostics' existing Multiple Award Schedule contract vehicle, with no...
- Roche Diagnostics Corporation received a $583,332.38 firm fixed-price delivery order from Veterans Integrated Service Network 5 (VISN 5) for chemistry and immunochemistry products and services, with a completion date of March 31, 2024. The award, issued on October 1, 2023, is a child contract under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration schedule and was made without a set-aside designation, reflecting open competition. Performance will occur at the...
- Roche Diagnostics Corporation received a delivery order award from Veterans Integrated Service Network 7 (VISN 7) for chemistry-immunochemistry services valued at $7.1 million with a completion date of May 31, 2029. This firm fixed-price contract, awarded June 1, 2024, was issued without a set-aside designation and will be performed in Castleton, Indiana. The award is a child contract under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) Master Schedule,...
- Roche Diagnostics Corporation was awarded a delivery order valued at approximately $21.4 million by the Department of Veterans Affairs' Veterans Integrated Service Network 8 on October 1, 2023. This firm fixed-price contract, with an ultimate completion date of November 28, 2025, will be performed in Castleton, Indiana. The delivery order was issued without a set-aside designation and is structured as a child contract under the General Services Administration's Critical Analyzers, Laboratory...
- Roche Diagnostics Corporation received a firm fixed-price delivery order valued at approximately $5.97 million from Veterans Integrated Service Network 7 (VISN 7), a civilian component of the Department of Veterans Affairs, for the supply of reagents. The contract, awarded on September 1, 2023, extends through August 31, 2028, and will be performed in Castleton, Indiana. This delivery order operates as a child contract under the General Services Administration's Critical Analyzers, Laboratory...
- Roche Diagnostics Corporation received a delivery order award valued at $294,964.39 for molecular pathology services from Veterans Integrated Service Network 12, a component of the Department of Veterans Affairs. This firm fixed-price contract, issued on April 1, 2025, with a completion date of September 30, 2025, represents a child order under a larger contract vehicle and carries no set-aside designation. The work will be performed in Castleton, Indiana. As a global leader in in vitro...
- Roche Diagnostics Corporation received a delivery order award valued at $1.97M from the Department of Veterans Affairs' Veterans Integrated Service Network 17 (VISN 17) for consumables, with a firm fixed-price structure and no set-aside designation. The contract, awarded on December 15, 2023, with an ultimate completion date of December 15, 2026, represents a child order under the GSA Schedule Critical Analyzers, Laboratory (FSS-66-III) master contract. Performance will take place at the...
- Roche Diagnostics Corporation has been awarded an Option Year 1 delivery order under the VCB Automation Line CPRR Blanket Purchase Agreement (BPA) by Veterans Integrated Service Network 17, a civilian healthcare entity within the Department of Veterans Affairs. This firm fixed-price BPA call carries a ceiling value of $1.0M and will be performed at Roche's facility in Castleton, Indiana, with completion targeted for June 30, 2026. The award is issued without set-aside designation, reflecting...
- Critical Analyzers, Laboratory (FSS-66-III)Master GSA Schedule
- V797P7347AFederal Supply Schedule
- V797P7347A-36C24820F0096Delivery Order
Roche Diagnostics Corporation received a $5.47 million firm fixed-price delivery order from Veterans Integrated Service Network 8 (VISN 8), a civilian healthcare agency within the Department of Veterans Affairs. The award, issued on June 1, 2020, with an ultimate completion date of March 31, 2025, represents a child contract under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule. The delivery order carries no set-aside designation and will be performed at Roche Diagnostics' facility in Castleton, Indiana. As a leading manufacturer of in vitro diagnostic systems, Roche Diagnostics supplies VISN 8 with diagnostic equipment, laboratory analyzers, reagents, and associated medical products and services to support veterans' healthcare delivery. This award reflects Roche Diagnostics' established position as a primary federal supplier of advanced diagnostic capabilities across the VA healthcare system and other federal agencies. The company maintains an extensive portfolio of indefinite delivery contracts and blanket purchase agreements valued at tens of millions of dollars across multiple Veterans Integrated Service Networks and the Defense Health Agency, providing molecular diagnostics, immunochemistry testing, histology staining services, point-of-care testing devices, and comprehensive maintenance support. The VISN 8 delivery order exemplifies the sustained demand for Roche's diagnostic solutions throughout the federal healthcare enterprise, with contracts extending through the 2020s supporting critical laboratory and diagnostic testing requirements for military, veterans, and civilian healthcare systems.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Roche Diagnostics Corporation Contract Award (5/15/2011 - 5/14/2016) | 66III | Department of Veterans Affairs National Acquisition Center | Award Notice 1/1 | 5/1/11, 12:15 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00012 | Other Administrative Action | ($167k) | 4/8/26 | |
| P00011 | Exercise an Option | $716.9k | 10/1/24 | |
| P00010 | Supplemental Agreement for work within scope | ($490k) | 6/28/24 | |
| P00009 | Supplemental Agreement for work within scope | $93.7k | 10/3/23 | |
| P00008 | Exercise an Option | $1.3m | 10/1/23 |